LO MINASTRIN - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87263903
Word Mark
LO MINASTRIN
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-11-09
Filing Date
2016-12-09
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2017-08-08
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
WEIGLE, KATHERINE CONN
Statements
Disclaimer with Predetermined Text
"LO"
Goods and Services
Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and formulations pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-12-14
Primary Code
005
Correspondences
Name
Matthew O. Brady
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2016-12-13 | NEW APPLICATION ENTERED IN TRAM |
2016-12-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2017-03-13 | ASSIGNED TO EXAMINER |
2017-03-13 | NON-FINAL ACTION WRITTEN |
2017-03-13 | NON-FINAL ACTION E-MAILED |
2017-03-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2017-06-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2017-06-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-06-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-06-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2017-07-19 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2017-08-08 | PUBLISHED FOR OPPOSITION |
2017-08-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-10-03 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2018-02-28 | TEAS EXTENSION RECEIVED |
2018-02-28 | EXTENSION 1 FILED |
2018-02-28 | EXTENSION 1 GRANTED |
2018-03-02 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-09-27 | TEAS EXTENSION RECEIVED |
2018-09-27 | EXTENSION 2 FILED |
2018-09-27 | EXTENSION 2 GRANTED |
2018-09-29 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-03-12 | TEAS EXTENSION RECEIVED |
2019-03-12 | EXTENSION 3 FILED |
2019-03-12 | EXTENSION 3 GRANTED |
2019-03-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-09-24 | TEAS EXTENSION RECEIVED |
2019-09-24 | EXTENSION 4 FILED |
2019-09-24 | EXTENSION 4 GRANTED |
2019-09-26 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-03-24 | TEAS EXTENSION RECEIVED |
2020-03-26 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-03-24 | EXTENSION 5 FILED |
2020-03-26 | EXTENSION 5 GRANTED |
2020-03-27 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-11-09 | ABANDONMENT - NO USE STATEMENT FILED |
2020-11-09 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |